HHS backs AstraZeneca COVID-19 vaccine candidate, could be ready by October

May 21, 2020 - 04:05 PM
Department of Health and Human Services (HHS) Seal

A collaboration between the Department of Health and Human Services and AstraZeneca is projected to make available 300 million doses of a COVID-19 vaccine, the first of which could be available as early as October, HHS today said.

The agreement is part of the White House’s Operation Warp Speed, a public-private effort to facilitate, at an unprecedented pace, the development, manufacturing and distribution of COVID-19 countermeasures. HHS says phase three clinical studies of AZD1222 are set to start in the summer. The Food and Drug Administration must still approve an emergency use authorization or licensure in order to make the vaccine available.

AZD1222 is the fourth vaccine candidate to receive HHS’ Biomedical Advanced Research and Development Authority support for late-state development and manufacturing. BARDA can provide up to $1.2 billion for vaccine manufacturing technology transfer, process development, scaled-up manufacturing and other development activities.

Related News Articles

Headline
CDC releases 2025-26 respiratory disease season outlook
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
OSHA extends comment period on proposal removing remaining COVID-19 emergency temporary standard requirements
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
CDC says COVID-19 cases growing or likely growing in 45 states 
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
COVID-19 vaccination approved for older adults and high-risk, younger children
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
OSHA proposes removing remaining requirements of its COVID-19 emergency temporary standard
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…